CDK4 and cancer: Moreover, the compound exerted direct anticancer activity, both in vitro and in vivo experiments, on cancer cells by cell-cycle arrest at G0/G1 phase through induction of cell-cycle inhibitory protein p27 and decreased expression of cyclin-dependent kinase 4 (CDK4) [33,36,37].